“Coartem” tablets contain artemether/lumefantrine 20mg/120mg. As such this anti-malaria medication is an “artemisinin-based combination treatment (ACT) for malaria”. This combination therapy has been reported to be highly effective even against multidrug resistant falciparum malaria (Am J Trop Med Hyg 2001; 64: 247-256, and Trans R Soc Trop Med Hyg 2000; 94: 545-548).
The company stated today that
the reason they can cut the price is: “Novartis has invested heavily to expand production
capacity at state-of-the-art facilities in
This full press release appears on the World Health Organization’s “World Malaria Day” website: www.rollbackmalaria.org/worldmalariaday/pressreleases.html
Additional positive information in the fight against the devastating disease of malaria is anticipated over the next 48 hours leading up to the first “World Malaria Day” April 25, 2008.
Daniel R. Lucey, MD, MPH
EROne Institutes, Department of Emergency Medicine
Department of Microbiology and Immunology
Website for this posting: www.BePast.org